Number of the records: 1  

Molecular Adjuvants Based on Nonpyrogenic Lipophilic Derivatives of norAbuMDP/GMDP Formulated in Nanoliposomes: Stimulation of Innate and Adaptive Immunity

  1. 1.
    SYSNO ASEP0443903
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleMolecular Adjuvants Based on Nonpyrogenic Lipophilic Derivatives of norAbuMDP/GMDP Formulated in Nanoliposomes: Stimulation of Innate and Adaptive Immunity
    Author(s) Turánek Knotigová, P. (CZ)
    Zyka, Daniel (UOCHB-X) RID
    Mašek, J. (CZ)
    Kovalová, Anna (UOCHB-X)
    Křupka, M. (CZ)
    Bartheldyová, E. (CZ)
    Kulich, P. (CZ)
    Koudelka, Š. (CZ)
    Lukáč, R. (CZ)
    Kauerová, Z. (CZ)
    Vacek, A. (CZ)
    Stuchlová Horynová, M. (CZ)
    Kozubík, Alois (BFU-R) RID, ORCID
    Miller, A. D. (GB)
    Fekete, Ladislav (FZU-D) RID, ORCID
    Kratochvílová, Irena (FZU-D) RID, ORCID, SAI
    Ježek, Jan (UOCHB-X) RID
    Ledvina, M. (CZ)
    Raška, M. (CZ)
    Turánek, J. (CZ)
    Number of authors20
    Source TitlePharmaceutical Research. - : Springer - ISSN 0724-8741
    Roč. 32, č. 4 (2015), s. 1186-1199
    Number of pages14 s.
    Languageeng - English
    CountryUS - United States
    Keywordsadjuvant ; bone-marrow radioprotection ; liposome ; muramyl dipeptide ; vaccine
    Subject RIVCC - Organic Chemistry
    Subject RIV - cooperationInstitute of Physics - Physical ; Theoretical Chemistry
    Institute of Biophysics - Biophysics
    R&D ProjectsGAP304/10/1951 GA ČR - Czech Science Foundation (CSF)
    TA01011165 GA TA ČR - Technology Agency of the Czech Republic (TA ČR)
    Institutional supportUOCHB-X - RVO:61388963 ; BFU-R - RVO:68081707 ; FZU-D - RVO:68378271
    UT WOS000351169800002
    EID SCOPUS84925507869
    DOI10.1007/s11095-014-1516-y
    AnnotationThe aim of this work was to demonstrate an immunostimulatory and adjuvant effect of new apyrogenic lipophilic derivatives of norAbuMDP and norAbuGMDP formulated in nanoliposomes. Nanoliposomes and metallochelating nanoliposomes were prepared by lipid film hydration and extrusion methods. The structure of the liposomal formulation was studied by electron microscopy, AF microscopy, and dynamic light scattering. Sublethal and lethal gamma-irradiation mice models were used to demonstrate stimulation of innate immune system. Recombinant Hsp90 antigen (Candida albicans) bound onto metallochelating nanoliposomes was used for immunisation of mice to demonstrate adjuvant activities of tested compounds. Safety and stimulation of innate and adaptive immunity were demonstrated on rabbits and mice. The liposomal formulation of norAbuMDP/GMDP was apyrogenic in rabbit test and lacking any side effect in vivo. Recovery of bone marrow after sublethal gamma-irradiation as well as increased survival of mice after lethal irradiation was demonstrated. Enhancement of specific immune response was demonstrated for some derivatives incorporated in metallochelating nanoliposomes with recombinant Hsp90 protein antigen. Liposomal formulations of new lipophilic derivatives of norAbuMDP/GMDP proved themselves as promising adjuvants for recombinant vaccines as well as immunomodulators for stimulation of innate immunity and bone-marrow recovery after chemo/radio therapy of cancer.
    WorkplaceInstitute of Organic Chemistry and Biochemistry
    Contactasep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Jana Procházková, Tel.: 220 183 418
    Year of Publishing2016
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.